schizophrenia

The FDA accepted Karuna Therapeutics’ new drug application for its investigational schizophrenia treatment xanomeline-trospium (KarXT) along with the EMERGENT clinical trial data, with a decision …

Nov 30 2023

Uncategorized

FDA Accepts New Drug Application For Karuna Therapeutics’ KarXT To Treat Schizophrenia

by Clinical Editor

No Comments

(RTTNews) – Karuna Therapeutics, Inc. (KRTX) Wednesday said the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for KarXT for the treatment of schizophrenia in...

Nov 30 2023

Uncategorized

Alleged UNC Campus Shooter Ruled Unfit For Trial—‘Likely’ Has Schizophrenia

by Clinical Editor

No Comments

Two psychiatric evaluations concluded the student—who was charged with murdering his professor at the University of North Carolina—“most likely” has schizophrenia.

Nov 30 2023

Uncategorized

FDA kicks off review of Karuna’s schizophrenia drug KarXT

by Clinical Editor

No Comments

Karuna Therapeutics said this morning that the FDA has formally started its review of KarXT, aiming to become the first drug to reach the market for schizophrenia with a new...

Nov 30 2023

Uncategorized

Ashley Weiss: Debunking myths about psychosis and schizophrenia

by Clinical Editor

No Comments

Ashley Weiss is the vice chair for Child and Adolescent Psychiatry for the Tulane School of Medicine. Weiss went to medical school in Florida and completed a psychiatry residency at...